C. Galambrun

J. Falkenburg, L. T. van der Veken, Y. Bertrand, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk‐adjusted monitoring of veno‐occlusive disease following Bayesian individualization of busulfan dosage for bone marrow transplantation in paediatrics

Y. Bertrand, V. Mialou, N. Bleyzac, 2008 .

Impact of viable CD45 cells infused on lymphocyte subset recovery after unrelated cord blood transplantation in children.

H. Chambost, C. Chabannon, A. Loundou, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Human parainfluenza virus type 4 infections: a report of 20 cases from 1998 to 2002.

B. Lina, O. Ferraris, M. Aymard, 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients.

A. Prieur, J. Stéphan, B. Bader-Meunier, 2001, Rheumatology.

Acquired Glanzmann's thrombasthenia associated with acute lymphoblastic leukemia.

Y. Bertrand, Y. Dargaud, V. Jallu, 2005, Journal of pediatric hematology/oncology.

Impact on long-term OS of conditioning regimen in allogeneic BMT for children with AML in first CR: TBI+CY versus BU+CY: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire

P. Rohrlich, A. Duhamel, Y. Bertrand, 2014, Bone Marrow Transplantation.

Impact of early molecular response in children with chronic myeloid leukemia treated in the French Glivec phase 4 study.

J. Cayuela, A. Baruchel, Y. Bertrand, 2014, Blood.

Human herpesvirus 6 infection and transient acquired myelodysplasia in children

Y. Bertrand, C. Négrier, V. Mialou, 2006, Pediatric blood & cancer.

Long-term event-free survival, chimerism and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and matched-sibling transplantation in France

M. Robin, Y. Bertrand, P. Rohrlich, 2019, Haematologica.

Assessment of chimerism and immunomodulation to prevent post-transplantation relapse in childhood acute myeloblastic leukemia: is it the right approach?

P. Rohrlich, E. Oger, P. Jonveaux, 2020, Pediatric hematology and oncology.

Syndrome d'activation lymphohistiocytaire chez 1'enfant*

J. Stéphan, C. Galambrun, 2000 .

Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond-like syndrome.

É. Oksenhendler, W. Vainchenker, T. Leblanc, 2018, Blood.

Ruxolitinib in children with steroid‐refractory acute graft‐versus‐host disease: A retrospective multicenter study of the pediatric group of SFGM‐TC

B. Neven, J. Dalle, V. Gandemer, 2020, Pediatric blood & cancer.

Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources

Y. Bertrand, Y. Bertrand, J. Bérard, 2003, Bone Marrow Transplantation.

French multicenter 22-year experience in stem cell transplantation for beta-thalassemia major: lessons and future directions.

P. Frange, Y. Bertrand, P. Schneider, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens.

Y. Bertrand, D. Angoulvant, A. Eljaafari, 2004, Biorheology.

Low incidence of sepsis due to viridans streptococci in a ten‐year retrospective study of pediatric acute myeloid leukemia

Y. Bertrand, C. Ploton, A. Freydiere, 2006, Pediatric blood & cancer.

Peripheral blood cells chimerism after unrelated cord blood transplantation in children: kinetics, predictive factors and impact on post‐transplant outcome

C. Oudin, H. Chambost, A. Loundou, 2014, British journal of haematology.

A. Fischer, E. López-Granados, E. Mejstrikova, 2011, Blood.

Innate lymphoid cell recovery and occurrence of GvHD after hematopoietic stem cell transplantation

F. Vély, C. Farnarier, É. Vivier, 2021, Journal of leukocyte biology.

Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic Anemia

M. Mohty, T. Leblanc, E. Deconinck, 2018, American journal of hematology.

Vancomycin in Pediatric Patients with Solid or Hematological Malignant Disease: Predictive Performance of a Population Pharmacokinetic Model and New Optimized Dosing Regimens

O. Blin, N. André, R. Guilhaumou, 2018, Pediatric Drugs.

Allogeneic hematopoietic stem cell transplant outcomes for patients with dominant negative IKZF1/IKAROS mutations.

S. Rosenzweig, A. Stray-Pedersen, D. Boutboul, 2019, The Journal of allergy and clinical immunology.

Epstein-Barr virus--positive undifferentiated thymic carcinoma in a 12-year-old white girl.

F. Varlet, E. Macintyre, J. Stéphan, 2000, Journal of pediatric hematology/oncology.

Weight‐based strategy of dose administration in children using intravenous busulfan: Clinical and pharmacokinetic results

D. Frappaz, G. Vassal, L. Nguyen, 2012, Pediatric blood & cancer.

In hematopoietic cells with a germline mutation of CBL, loss of heterozygosity is not a signature of juvenile myelo-monocytic leukemia

A. Baruchel, H. Cavé, T. Blauwblomme, 2013, Leukemia.

Inolimomab in Steroid-Refractory Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation: Retrospective Analysis and Comparison with Other Interleukin-2 Receptor Antibodies

A. Fischer, A. Stamatoullas, I. Yakoub-Agha, 2005, Transplantation.

Invasive aspergillosis and allogeneic hematopoietic stem cell transplantation in children: a 15‐year experience

Y. Bertrand, M. Piens, C. Galambrun, 2008, Transplant infectious disease : an official journal of the Transplantation Society.

Invasive aspergillosis in a paediatric haematology department: a 15‐year review

Y. Bertrand, M. Piens, C. Pondarré, 2008, Mycoses.

EFFICACY AND SAFETY OF CASPOFUNGIN THERAPY IN CHILDREN WITH INVASIVE FUNGAL INFECTIONS

J. Stéphan, P. Ribaud, É. Merlin, 2006, The Pediatric infectious disease journal.

J. Soulier, G. Socié, J. Dalle, 2015, Blood.

Cytomegalovirus and adenovirus infections and diseases among 75 paediatric unrelated allogeneic bone marrow transplant recipients

Y. Bertrand, F. Bienvenu, M. Aymard, 2004, Journal of medical virology.

Health status of childhood leukemia survivors who received hematopoietic cell transplantation after BU or TBI: an LEA study

P. Auquier, H. Chambost, J. Berbis, 2014, Bone Marrow Transplantation.

The Impact of Donor Type on Long-Term Health Status and Quality of Life after Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Leucémie de l'Enfant et de L'Adolescent Study.

P. Auquier, A. Baruchel, G. Leverger, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Human cytomegalovirus (HCMV) laryngitis: atypical HCMV disease presentation in haematopoietic stem cell transplantation.

Y. Bertrand, V. Escuret, N. Lévêque, 2008, Journal of Medical Microbiology.

Successful treatment of Evans syndrome post liver transplant with splenectomy and switch from tacrolimus to cyclosporine

Y. Bertrand, F. Dijoud, V. Mialou, 2008, Transplant international : official journal of the European Society for Organ Transplantation.

Incidence and risk factors for cataract after haematopoietic stem cell transplantation for childhood leukaemia: an LEA study

P. Auquier, C. Oudin, Y. Bertrand, 2015, British journal of haematology.

Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network

A. Baruchel, C. Picard, H. Cavé, 2015, Nature Genetics.

BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.

Valérie Rigau, Valérie Taly, Christine Bodemer, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical, Functional and Genetic Analysis of Twenty-Four Patients with Chronic Granulomatous Disease – Identification of Eight Novel Mutations in CYBB and NCF2 Genes

B. Conrad, M. Callanan, J. Stéphan, 2012, Journal of Clinical Immunology.

Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia

J. Stéphan, C. Berger, J. Donadieu, 2005, Bone Marrow Transplantation.

New dosing nomogram and population pharmacokinetic model for young and very young children receiving busulfan for hematopoietic stem cell transplantation conditioning

S. Broutin, O. Mir, A. Paci, 2020, Pediatric blood & cancer.

Pharmacokinetic Behavior and Appraisal of Intravenous Busulfan Dosing in Infants and Older Children: The Results of a Population Pharmacokinetic Study From a Large Pediatric Cohort Undergoing Hematopoietic Stem-Cell Transplantation

S. Broutin, A. Paci, G. Vassal, 2012, Therapeutic drug monitoring.

Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring

G. Vassal, L. Nguyen, B. Neven, 2007, Cancer Chemotherapy and Pharmacology.

Severe neurologic complication after delayed hemolytic transfusion reaction in 2 children with sickle cell anemia: significant diagnosis and therapeutic challenges.

Y. Bertrand, N. Elenga, C. Pondarré, 2008, Journal of pediatric hematology/oncology.

Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg®) in children with relapsed/refractory myeloid leukemia

A. Baruchel, G. Leverger, T. Leblanc, 2006, BMC Cancer.

Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia

A. Baruchel, H. Cavé, N. Philip, 2010, Journal of Medical Genetics.

Aplastic anemia after Mycoplasma pneumoniae infection: a report of two cases.

B. Pozzetto, P. Bordigoni, F. Grattard, 1999, Journal of pediatric hematology/oncology.

Pediatric Patients With Solid or Hematological Tumor Disease: Vancomycin Population Pharmacokinetics and Dosage Optimization

N. André, J. Dupouey, R. Guilhaumou, 2016, Therapeutic drug monitoring.

Primary lymphoma of the pituitary stalk in an immunocompetent 9-year-old child.

Y. Bertrand, M. Nicolino, L. Guibaud, 2001, Medical and pediatric oncology.

Antileukemic and long-term effects of two regimens with or without TBI in allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia

Y. Bertrand, Y. Bertrand, P. Berlier, 2004, Bone Marrow Transplantation.

Interleukin‐7 receptor α (IL‐7Rα) deficiency: cellular and molecular bases. Analysis of clinical, immunological, and molecular features in 16 novel patients

A. Fischer, S. Dupuis, L. Notarangelo, 2005, Immunological reviews.

Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study

K. Hoang-Xuan, G. Leverger, A. Idbaih, 2018, British journal of haematology.

Human herpes virus-6 encephalitis in a paediatric bone marrow recipient: successful treatment with pharmacokinetic monitoring and high doses of ganciclovir

Y. Bertrand, V. Mialou, N. Bleyzac, 2006, Bone Marrow Transplantation.

Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30‐year nationwide cohort of 1478 patients under 18 years of age

K. Hoang-Xuan, J. Emile, Y. Bertrand, 2016, British journal of haematology.

Cytogenetics and outcome of allogeneic transplantation in first remission of acute myeloid leukemia: the French pediatric experience

A. Baruchel, G. Leverger, P. Rohrlich, 2017, Bone Marrow Transplantation.

A Phase I Study of Clofarabine With Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (VANDEVOL Study of the French SFCE Acute Leukemia Committee)

A. Baruchel, G. Leverger, H. Cavé, 2016, Pediatric blood & cancer.

Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens

Y. Bertrand, P. Magron, N. Bleyzac, 2001, Bone Marrow Transplantation.

Successful match-unrelated donor bone marrow transplantation for congenital erythropoietic porphyria (Günther disease)

C. Ged, J. Deybach, Y. Bertrand, 2005, European Journal of Pediatrics.

Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial

M. De Carvalho Bittencourt, L. Reppel, D. Bensoussan, 2017, Journal of Hematology & Oncology.

Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Workin

F. Tana, G. Dini, A. Verdeguer, 2007, Bone Marrow Transplantation.

Single- vs double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome.

K. Baumstarck, A. Loundou, I. Yakoub-Agha, 2016, Blood.

Single-Unit versus Double-Unit Umbilical Cord Blood Transplantation in Children and Young Adults with Residual Leukemic Disease.

K. Baumstarck, A. Loundou, I. Yakoub-Agha, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC

J. Bay, B. Neven, G. Socié, 2015, Transplantation.

Photopheresis in pediatric graft‐versus‐host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature

J. Stéphan, C. Berger, A. Marabelle, 2007, Transfusion.

G. Socié, N. Milpied, P. Bordigoni, 2007, Haematologica.

Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors

Y. Bertrand, N. Bleyzac, C. Galambrun, 2003, Bone Marrow Transplantation.

HSCT may lower leukemia risk in ELANE neutropenia: a before–after study from the French Severe Congenital Neutropenia Registry

C. Bellanné-Chantelot, Y. Bertrand, B. Neven, 2020, Bone Marrow Transplantation.

Double reduced-intensity allogeneic hematopoietic stem cell transplantation: a retrospective study from the SFGM-TC.

M. Robin, P. Chevallier, D. Blaise, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Assessment of the Purity of Isolated Cd3+ T Cell Populations by A New Molecular Biology Technology: Impact on the Quantification of Chimerism Monitoring After Hematopoietic Stem Cell Transplantation

J. Chiaroni, A. Basire, C. Picard, 2019, Biomedical Journal of Scientific & Technical Research.

S. Chevret, M. Mohty, J. Larghero, 2018, Blood.

A French cohort of childhood leukemia survivors: impact of hematopoietic stem cell transplantation on health status and quality of life.

K. Baumstarck, P. Auquier, H. Chambost, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

E. Bosdure, N. Stremler, P. Petit, 2018, Pediatric blood & cancer.

Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the société Francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

I. Yakoub-Agha, M. Mohty, Y. Bertrand, 2017, Bone Marrow Transplantation.

Medication non‐adherence after allogeneic hematopoietic cell transplantation in adult and pediatric recipients: a cross sectional study conducted by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

J. Bourhis, I. Yakoub-Agha, J. Bay, 2020, Fundamental & clinical pharmacology.

Successful allogeneic hematopoietic stem cell transplantation for DOCK8 deficiency.

A. Fischer, C. Picard, J. Stéphan, 2011, The Journal of allergy and clinical immunology.

Myelofibrosis: an unusual presentation of vitamin D-deficient rickets

F. Freycon, C. Galambrun, J. Stéphan, 1999, European Journal of Pediatrics.

Overexpression of the antiapoptotic gene Bfl-1 in B cells from patients with familial systemic lupus erythematosus

F. Rieux-Laucat, B. Ranchin, R. Bouvier, 2007, Lupus.

Influence of Underlying Disease on Busulfan Disposition in Pediatric Bone Marrow Transplant Recipients: A Nonparametric Population Pharmacokinetic Study

Y. Bertrand, V. Mialou, N. Bleyzac, 2007, Therapeutic drug monitoring.

Screening for Potential Covariates Influencing the Pharmacokinetics of Intravenous Busulfan: Results From a Large Pediatric Cohort Undergoing Hematopoietic Stem-Cell Transplantation

S. Broutin, A. Paci, G. Vassal, 2010 .

Imatinib Is Efficient but Has a Negative Impact On Growth in Children with Previously Untreated chronic Myelogenous Leukaemia (CML) in Early Chronic Phase (CP): Results of the French National Phase IV Trial.

J. Cayuela, A. Baruchel, T. Leblanc, 2009 .

2019 CIS Annual Meeting: Immune Deficiency & Dysregulation North American Conference

S. Rosenzweig, L. Forbes, H. Kuehn, 2019, Journal of Clinical Immunology.

[Reactive hemophagocytic syndrome in children].

J. Stéphan, C. Galambrun, 2000, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

Hepatitis E in three immunocompromized children in southeastern France.

P. Colson, C. Zandotti, B. Roquelaure, 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.